Perrigo confirms ambitions for UK, strong 2Q
reported a record second quarter this week and confirmed that it
was ready to become a leading nutritional products supplier in the
British market.
Perrigo, the US' biggest manufacturer of supermarket brand supplements, saw net sales climb 8 per cent in the second quarter to $245.1 million while net income, excluding a one-time income tax benefit, jumped 49 per cent to a record $25.1 million.
David T. Gibbons, Perrigo chairman and CEO, said the impressive result was thanks to stronger than anticipated new product sales and the early onset of flu this year, which boosted sales of cough and cold products.
The quarter's results also included a one-time income tax benefit of $13.1 million, or $0.18 per share, resulting from the a Federal tax examination of tax years 1998, 1999 and 2000. This brought profits up to $38.2 million, or $0.53 per share, compared with $16.8 million, or $0.24 per share, a year ago.
"Perrigo continues to make good progress in improving operationalefficiencies. These same strategies were key contributors to the increase in year-to-date operating cash flow to $60 million, a 58 per cent increase compared with $38 million last year," said Gibbons.
Net sales for the six months rose by 3 per cent and income for the first half of the year came to $54.7 million, or $0.76 per share, compared with $35.6 million, or $0.50 per share, last year.
The company bought Peter Black Pharmaceuticals, the UK's largest store brand supplement makers, for $13.4 million in cash at the end of last year and says it is now on its way to becoming a leading OTC pharmaceutical and nutritional products supplier in the British market.
However while sales were up marginally in the second quarter at the UK operations, operating profit has slipped to $900,000 from $1.04 million the previous year and by 25 per cent over the six-month period to date.
